Sangamo Biosciences reported $772.4M in Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acceleron Pharma XLRN:US $ 787.85M 48.2M
Alnylam Pharmaceuticals ALNY:US $ 3472.31M 37.12M
Amgen AMGN:US $ 64993M 5220M
Avrobio Inc AVRO:US $ 216.45M 21.64M
Bayer BAYN:GR € 116549M 2122M
Biocryst Pharmaceuticals BCRX:US $ 265.76M 11.52M
Biogen BIIB:US $ 23806.7M 663.7M
Biomarin Pharmaceutical BMRN:US $ 5977.48M 78.98M
Bluebird Bio BLUE:US $ 1339.64M 114.82M
Gilead Sciences GILD:US $ 67098M 886M
GlaxoSmithKline GSK:LN 78689M 1678M
Intercept Pharmaceuticals ICPT:US $ 523.07M 0.15M
IONIS PHARMACEUT IONS:US $ 2415M 82.07M
Karyopharm Therapeutics KPTI:US $ 254.09M 32.47M
Novartis NOVN:VX SF 121209M 2806M
Omeros OMER:US $ 123.43M 21.96M
Sangamo Biosciences SGMO:US $ 772.4M 62.96M
Sarepta Therapeutics SRPT:US $ 2662.22M 96.86M
Ultragenyx Pharmaceutical RARE:US $ 1484.8M 27.64M
Vertex Pharmaceuticals VRTX:US $ 12618.74M 397.06M
Ziopharm Oncology ZIOP:US $ 113.76M 7M